[Pancreatic cancer: Roche versus the European Agency of Drugs].
Nau
Jean-Yves
JY
D017277:Drug Approval; D004345:Drug Industry; D000069347:Erlotinib Hydrochloride; D005062:European Union; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride